JP2022521605A5 - - Google Patents
Info
- Publication number
- JP2022521605A5 JP2022521605A5 JP2021549625A JP2021549625A JP2022521605A5 JP 2022521605 A5 JP2022521605 A5 JP 2022521605A5 JP 2021549625 A JP2021549625 A JP 2021549625A JP 2021549625 A JP2021549625 A JP 2021549625A JP 2022521605 A5 JP2022521605 A5 JP 2022521605A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- alkyl
- pharmaceutically acceptable
- och
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962810324P | 2019-02-25 | 2019-02-25 | |
| US62/810,324 | 2019-02-25 | ||
| US201962943643P | 2019-12-04 | 2019-12-04 | |
| US62/943,643 | 2019-12-04 | ||
| PCT/US2020/019552 WO2020176428A1 (en) | 2019-02-25 | 2020-02-24 | Inhibitors of integrated stress response pathway |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022521605A JP2022521605A (ja) | 2022-04-11 |
| JP2022521605A5 true JP2022521605A5 (cg-RX-API-DMAC10.html) | 2023-03-06 |
Family
ID=72141533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021549625A Pending JP2022521605A (ja) | 2019-02-25 | 2020-02-24 | 統合的ストレス応答経路の阻害剤 |
Country Status (13)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021508336A (ja) | 2017-12-13 | 2021-03-04 | プラクシス バイオテック エルエルシー | 統合的ストレス応答経路の阻害剤 |
| US11166942B2 (en) | 2018-06-05 | 2021-11-09 | Praxis Biotech LLC | Inhibitors of integrated stress response pathway |
| JP2022536663A (ja) | 2019-06-12 | 2022-08-18 | プラクシス バイオテック エルエルシー | 統合的ストレス応答経路のモジュレーター |
| KR20220151635A (ko) | 2020-03-11 | 2022-11-15 | 에보텍 인터내셔널 게엠베하 | 통합 스트레스 반응 경로의 조절제 |
| CA3195290A1 (en) | 2020-10-22 | 2022-04-28 | Holly Victoria Atton | Modulators of the integrated stress response pathway |
| MX2023004677A (es) | 2020-10-22 | 2023-05-24 | Evotec Int Gmbh | Moduladores de la via de respuesta integrada al estres. |
| ES2997335T3 (en) | 2020-10-22 | 2025-02-17 | Evotec Int Gmbh | Modulators of the integrated stress response pathway |
| EP4001917A1 (en) | 2020-11-12 | 2022-05-25 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | Inhibitors for use in treating liver disorders |
| WO2023014431A1 (en) * | 2021-08-02 | 2023-02-09 | The Regents Of The University Of Colorado | Bacterial efflux pump inhibitors and methods of use |
| KR102992203B1 (ko) * | 2024-02-05 | 2026-07-20 | 재단법인 대구경북첨단의료산업진흥재단 | 신규한 eIF2B 작용제 및 이를 포함하는 대사질환 예방 또는 치료용 조성물 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050197350A1 (en) * | 2003-03-31 | 2005-09-08 | Taisho Pharmaceutical Co., Ltd. | Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof |
| JP4868731B2 (ja) * | 2004-11-17 | 2012-02-01 | 独立行政法人理化学研究所 | 哺乳動物培養細胞由来の無細胞タンパク質合成システム |
| WO2014072061A1 (en) * | 2012-11-09 | 2014-05-15 | Biontech Ag | Method for cellular rna expression |
| WO2014144952A2 (en) * | 2013-03-15 | 2014-09-18 | Peter Walter | Modulators of the eif2alpha pathway |
| TW201808903A (zh) * | 2016-05-05 | 2018-03-16 | 嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
| TWI920577B (zh) * | 2016-05-05 | 2026-04-01 | 美商嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
| TW201808888A (zh) * | 2016-05-05 | 2018-03-16 | 嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
| CA3026983A1 (en) * | 2016-06-08 | 2017-12-14 | Glaxosmithkline Intellectual Property Development Limited | Chemical compounds |
-
2020
- 2020-02-24 SG SG11202107871UA patent/SG11202107871UA/en unknown
- 2020-02-24 WO PCT/US2020/019552 patent/WO2020176428A1/en not_active Ceased
- 2020-02-24 EP EP20763810.7A patent/EP3930697A4/en not_active Withdrawn
- 2020-02-24 CA CA3130511A patent/CA3130511A1/en active Pending
- 2020-02-24 MX MX2021010106A patent/MX2021010106A/es unknown
- 2020-02-24 JP JP2021549625A patent/JP2022521605A/ja active Pending
- 2020-02-24 AU AU2020229748A patent/AU2020229748A1/en not_active Abandoned
- 2020-02-24 BR BR112021014514-1A patent/BR112021014514A2/pt not_active IP Right Cessation
- 2020-02-24 KR KR1020217030624A patent/KR20210134351A/ko not_active Withdrawn
- 2020-02-24 US US16/799,765 patent/US20200270232A1/en not_active Abandoned
- 2020-02-24 CN CN202080016491.2A patent/CN113840597A/zh active Pending
-
2021
- 2021-08-18 IL IL285697A patent/IL285697A/en unknown
- 2021-08-24 CL CL2021002238A patent/CL2021002238A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021527044A5 (cg-RX-API-DMAC10.html) | ||
| JP2022536663A5 (cg-RX-API-DMAC10.html) | ||
| RU2020122711A (ru) | Ингибиторы пути интегрированной реакции на стресс | |
| JP2022536901A5 (cg-RX-API-DMAC10.html) | ||
| JP2020525512A (ja) | 癌および他の疾患を処置するためのATF4阻害剤としての2−(4−クロロフェノキシ)−N−((1−(2−(4−クロロフェノキシ)エチンアゼチジン(ethynazetidin)−3−イル)メチル)アセトアミド誘導体および関連化合物 | |
| JP6739548B2 (ja) | ベンザゼピン誘導体、その製造方法、薬物組成物および使用 | |
| JP2021529814A (ja) | 化学化合物 | |
| US20200297710A1 (en) | Chemical Compounds | |
| JP2022536663A (ja) | 統合的ストレス応答経路のモジュレーター | |
| JP2024509962A (ja) | 複素環及びその使用 | |
| WO2020031107A1 (en) | Chemical compounds | |
| US9963464B2 (en) | Macrocyclic compounds | |
| CN114174281A (zh) | 细胞周期蛋白依赖性激酶7(cdk7)的降解剂及其用途 | |
| SG11202107871UA (en) | Inhibitors of integrated stress response pathway | |
| JP2022542669A (ja) | Irak4キナーゼ阻害剤及びその調製方法 | |
| US20200101047A1 (en) | Inhibitors of integrated stress response pathway | |
| CA3255890A1 (en) | Conjugate comprising toll-like receptor agonist | |
| JP2010526867A5 (cg-RX-API-DMAC10.html) | ||
| JP7014914B2 (ja) | 血管炎及び炎症性疾患を治療するためのc5a受容体調節剤としての2,4,6,7-テトラヒドロ-ピラゾロ[4,3-d]ピリミジン-5-オン誘導体及び関連化合物 | |
| CA3001085A1 (en) | Novel modified macrocyclic compounds | |
| AU2015274285C1 (en) | Pyrimidine compounds and methods using the same | |
| CA2999931A1 (en) | Novel macrocyclic sulfondiimine compounds | |
| JP7329052B2 (ja) | フッ素含有置換ベンゾチオフェン化合物ならびにその医薬組成物および応用 | |
| RU2021128007A (ru) | Ингибиторы пути интегрированной реакции на стресс | |
| WO2013147216A1 (ja) | (2-ヘテロアリールアミノ)コハク酸誘導体 |